Variants of the post-COVID syndrome course depending on age, gender, comorbidity and severity of COVID-19


BACKGROUND. Among residents of Chernivtsi region, the main characteristics, frequency and peculiarities of the longterm symptomatic and post-COVID-19 syndrome have not been sufficiently studied.

OBJECTIVE. To evaluate the variants of the post-COVID syndrome course depending on age, gender, comorbidity and severity course of coronavirus disease (COVID-19).

MATERIALS AND METHODS. The following research methods were used: electronic questionnaire, epidemiological, clinical and anamnestic, analytical and statistical methods. The study included 214 adult patients infected with SARS-CoV-2 virus (diagnosis was confirmed by polymerase chain reaction) and suffering from COVID-19 of varying severity. The patients were randomized into two groups: the main group included 112 people (63 men – 56.4 % and 49 women – 47.5 %); the comparison group included 102 patients with mild and moderate severity of COVID-19 who were consulted and treated outpatiently (46 men – 45.5 % and 56 women – 54.5 %). Statistical data processing was carried out using the IBM SPSS Statistics v26.0 program.

RESULTS AND DISCUSSION. It was found that among inpatients, there was a significantly higher number of patients over 60 years of age (p<0.001), whereas among outpatients, people aged 18-29 years prevailed. This indicates the relationship between the age of the respondents and the need for inpatient treatment in case of COVID-19. In the main group, the following symptoms occurred more frequently (p<0.05): cough (odds ratio, OR 2.023; confidence interval, CI 1.105-3.703), fever (OR 6.916; CI 2.061-23.204), shortness of breath – dyspnea (OR 4.421; CI 2.230-8.764). In the comparison group, the following prevailed: loss of smell (OR 0.147; CI 0.077-0.281), fatigue (OR 0.456; CI 0.226-0.920), increased body temperature (OR 2.023; CI 2.061-23.204). In patients who were admitted to the hospital, the following comorbidities prevailed: coronary heart disease (OR 33.088; CI 9.444-115.930), arterial hypertension (OR 13.641; CI 6.547-28.422), diabetes mellitus (OR 4.755; CI 1.915-11.803), heart failure (OR 18.504; CI 8.200-41.752), obesity (OR 4.828; CI 2.433-9.581).

CONCLUSIONS. 1. Among the patients who were admitted to the hospital, the vast majority are people over 40 years of age; men of a younger age (from 40 years) prevailed in contrast to women (over 60 years). 2. In persons with severe COVID-19, shortness of breath, cough, difficulty breathing, chest pain were registered more often. On outpatient treatment, loss of smell and fatigue prevailed. 3. In patients admitted to the hospital, the following comorbidities prevailed: coronary heart disease (37.5 %), arterial hypertension (57.4 %), diabetes mellitus (21.3 %), heart failure (54.1 %), obesity (41.1 %). Smoking and alcohol abuse did not show significant reliable differences. 4. The most common combination of three pathologies (hypertension, heart failure, obesity) was found in 11 people (10 %).

Keywords: post-COVID syndrome, COVID-19, comorbidity, gender, age


Holubovska O.A. Postkovidnyy syndrom: patohenez ta osnovni napryamy reabilitatsiyi. Medychna hazeta “Zdorovya Ukrayiny”. 2021; 2 (495).

Protsyuk R.G., Vlasova-Protsyuk G.J., Galan I.O. COVID-19: prevention of infection and spread. Tuberculosis. Lung disease. HIV-infection. 2022; 4 (51): 30-5.

Todoriko L.D., Feshchenko Yu.I., Semіaniv I.O., Kuzhko M.M., Shevchenko O.S., Lyubevich R.L. Peculiarities of the pathogenesis of coronavirus infection and prognosis regarding the pathomorphosis of pulmonary tuberculosis in the conditions of the COVID-19 pandemic. Ukr. Pulmonol. Journal. 2022; 2-3: 12-22.

Todoriko L.D., Ostrovskyi M.M., Semianiv I.O., Shevchenko O.S. Features of tuberculosis in a COVID-19 pandemic. Tuberculosis. Lung disease. HIV-infection. 2020; 4 (43): 52-63.

Shevchenko O.S., Todoriko L.D., Petrenko V.I., Kiba V.P., Pohorielova O.O. COVID-19 and mental disorders: mechanisms of development and possibility of detection: a review. Tuberculosis. Lung disease. HIV-infection. 2021; 2 (45): 52-9.

Carfi A., Bernabei R., Landi F. Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020; 324 (6): 603-5.

Cheung K.S., Hung I.F.N., Chan P.Y., Lung K.C., Tso E., Liu R., et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and metaanalysis. Gastroenterology. 2020 Jul; 159 (1): 81-95.

COVID-19 long term health effects. Available at:

Eysenbach G. Improving the Quality of Web Surveys: The Checklist for Reporting Results of Internet E-Surveys (CHERRIES). J. Med. Internet Res. 2012; 14 (1): e8. doi: 10.2196/jmir.2042.

Gupta A., Madhavan M.V., Sehgal K., Nair N., Mahajan S., Tejasav S., et al. Extrapulmonary manifestations of COVID-19. Nat. Med. 2020; 26: 1017-32.

Klok F.A., Boon G.J.A.M., Barco S., Endres M., Geelhoed J.J.M., Knauss S., еt al. The Post-COVID-19 Functional Status (PCFS) Scale: a tool to measure functional status over time after COVID-19. Eur. Respir. J. 2020 Jul; 56 (1): 2001494. doi: 10.1183/13993003.01494-2020.

Komaroff A. The tragedy of the post-COVID “long haulers”. Available at:

Moreno-Pérez O., Merino E., Leon-Ramirez J.M., Prunier L., Cavelier G., Thill M.P., et al. COVID19-ALC research post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J. Infect. 2021 Mar; 82 (3): 378-83. doi: 10.1016/j.jinf.2021.01.004.

Pavli A., Theodoridou M., Maltezou H.C. Post-COVID syndrome: incidence, clinical spectrum, and challenges for primary healthcare professionals. Arch. Med. Res. 2021; 52 (6): 575-81. doi: 10.1016/j.arcmed.2021.03.010.

Shah W., Hillman T., Playford E.D., Hishmeh L. Managing the long term effects of COVID-19: summary of NICE, SIGN, and RCGP rapid guideline. Brit. Med. J. 2021; 372: n136.

Velavan T., Meyer C. The COVID-19 epidemic. Trop. Med. Int. Health. 2020; 25 (3): 278-80.

How to Cite
Todoriko, L., & Shevchenko, O. (2023). Variants of the post-COVID syndrome course depending on age, gender, comorbidity and severity of COVID-19. Infusion & Chemotherapy, (1), 14-19.

Author Biographies

L.D. Todoriko, Bukovinian State Medical University, Chernivtsi, Ukraine

Todoriko Lilia Dmytrivna
Head of the phthisiology and pulmonology department
MD, professor.
2, Theatralna sq., Chernivtsi, 58002, Ukraine.

O.S. Shevchenko, Kharkiv National Medical University, Kharkiv, Ukraine

Shevchenko Olga Stanislavna
Head of the phthisiology and pulmonology department
MD, professor.
4, Nauky ave., Kharkiv, 61022, Ukraine.

Most read articles by the same author(s)